Sg Americas Securities, LLC Adma Biologics, Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 6,554 shares of ADMA stock, worth $104,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,554

Previous 44,192 85.17%

Holding current value

$104,995

Previous $883,000 87.32%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$15.62 - $22.62 $587,905 - $851,371	-37,638 Reduced 85.17%	6,554 $112,000
Q3 2024 Oct 03, 2024	SELL	$11.21 - $20.03 $3.58 Million - $6.4 Million	-319,550 Reduced 87.85%	44,192 $883,000
Q2 2024 Jul 12, 2024	BUY	$5.98 - $11.18 $2.11 Million - $3.94 Million	352,320 Added 3084.57%	363,742 $4.07 Million
Q1 2024 May 06, 2024	SELL	$4.4 - $6.74 $359,981 - $551,426	-81,814 Reduced 87.75%	11,422 $75,000
Q4 2023 Jan 12, 2024	BUY	$3.08 - $4.52 $231,656 - $339,962	75,213 Added 417.32%	93,236 $421,000
Q3 2023 Oct 13, 2023	BUY	$3.47 - $4.61 $62,539 - $83,086	18,023 New	18,023 $65,000
Q1 2023 Apr 28, 2023	BUY	$3.01 - $3.87 $88,274 - $113,495	29,327 Added 100.5%	58,507 $194,000
Q4 2022 Feb 02, 2023	SELL	$2.47 - $3.88 $279,828 - $439,569	-113,291 Reduced 79.52%	29,180 $113,000
Q3 2022 Oct 31, 2022	BUY	$2.03 - $2.86 $194,977 - $274,697	96,048 Added 206.9%	142,471 $346,000
Q2 2022 Jul 29, 2022	BUY	$1.43 - $2.2 $66,384 - $102,130	46,423 New	46,423 $92,000
Q2 2021 Aug 12, 2021	SELL	$1.51 - $2.07 $28,641 - $39,263	-18,968 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.67 - $2.95 $7,084 - $12,513	-4,242 Reduced 18.28%	18,968 $33,000
Q4 2020 Feb 04, 2021	BUY	$1.8 - $2.56 $41,778 - $59,417	23,210 New	23,210 $45,000
Q3 2020 Nov 09, 2020	SELL	$2.04 - $3.74 $241,128 - $442,068	-118,200 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$2.42 - $3.29 $18,295 - $24,872	-7,560 Reduced 6.01%	118,200 $346,000
Q1 2020 Apr 30, 2020	BUY	$1.5 - $4.59 $188,640 - $577,238	125,760 New	125,760 $362,000

Others Institutions Holding ADMA

# of Institutions

317

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.15B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Adma Biologics, Inc. Transaction History